Live Quote · NASDAQRGENHealthcare· Medical - Instruments & Supplies

Repligen Corporation

$163.81▼ 3.81%($-6.48)
MKT CAP $10.47BNEXT EARNINGS Feb 23, 2027
50%
Bullish
TickerSpark Score
70/100
▌ Solid
56
Valuation
40
Profitability
95
Growth
100
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGEN research report →

Analyst Price Target
$198.00+20.9% vs. today

Range $160 – $225

Analyst RatingBuy
22 Buy2 Hold0 Sell

Price Chart

+6.12% · this period
$194.57$148.72$102.87Nov 20May 26Nov 20
52-Week Range64% of range
Low
$100.99
Current
$163.81
High
$198.87

AI analysis · Last refreshed November 21, 2026 · Live quote · Not investment advice